4//SEC Filing
Buckley Robert 4
Accession 0001076930-26-000031
CIK 0001076930other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:17 PM ET
Size
9.8 KB
Accession
0001076930-26-000031
Research Summary
AI-generated summary of this filing
Novanta (NOVT) CFO Robert Buckley Exercises Options and Sells 1,423 Shares
What Happened
- Robert Buckley, Chief Financial Officer of Novanta Inc. (NOVT), exercised 1,423 stock options at $14.13 per share (cost $20,107) and immediately sold those 1,423 shares in the open market at a weighted-average price of $140.14 per share for gross proceeds of $199,424. The transactions were reported for 2026‑01‑21 and filed with the SEC on 2026‑01‑23.
Key Details
- Transaction date: January 21, 2026; Form filed: January 23, 2026 (appears timely under the SEC’s 2‑business‑day rule).
- Exercise (derivative acquisition): 1,423 shares @ $14.13 (total exercise cost $20,107).
- Sale (open market): 1,423 shares @ weighted‑avg $140.14 (total proceeds $199,424). Footnote says trades ranged $140.00–$140.24 and price shown is weighted average.
- Derivative disposition reported at $0 reflects conversion/exercise of the options into shares.
- Shares owned after the transaction: not specified in the information provided in this summary (see Form 4 for current holdings).
- Footnotes: sale executed under a pre‑established Rule 10b5‑1 trading plan adopted March 13, 2025; the options exercised vested in three equal installments on March 30, 2017, 2018 and 2019. Power of attorney is on file.
Context
- This sequence (exercise followed by an immediate sale) is commonly a cashless exercise: the option is exercised and the resulting shares are sold right away. Net cash proceeds to the insider before taxes/fees are roughly $199,424 − $20,107 ≈ $179,317.
- The filing is factual and routine in nature (no inference should be made about the company’s outlook based solely on this sale).
Insider Transaction Report
Form 4
NOVANTA INCNOVT
Buckley Robert
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-21$14.13/sh+1,423$20,107→ 92,457 total - Sale
Common Stock
[F1][F2]2026-01-21$140.14/sh−1,423$199,424→ 91,034 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F3]2026-01-21−1,423→ 11,380 totalExercise: $14.13Exp: 2026-03-30→ Common Stock (1,423 underlying)
Holdings
- 36,219(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
- [F2]This transaction was executed in multiple trades ranging from $140.00 to $140.24. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The Stock Options vested in three equal installments on March 30, 2017, March 30, 2018, and March 30, 2019.
Signature
/s/ John Burke, Attorney-in-Fact|2026-01-23
Documents
Issuer
NOVANTA INC
CIK 0001076930
Entity typeother
Related Parties
1- filerCIK 0001513778
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 4:17 PM ET
- Size
- 9.8 KB